Managing household income and antiretroviral therapy adherence among people living with HIV in a low-income setting: a qualitative data from the HPTN 071 (PopART) trial in South Africa.

"Declarations Competing interestsThe authors declare no competing interests. Ethical approvalThe ethics approval of this study was granted by the Health Research Ethics Committee (HREC) at Stellenbosch University (Ref no. S19/10/227). Additionally, since the study has drawn on data collected in the context of the HPTN 071 (PopART) trial, permission to use data for the purpose of this research project was granted by the principal investigators of the larger trial. All participants provided written informed consent and consent was repeatedly confirmed during data collection process. No risks or harm took place on participants during data collection. I anonymised any data presented publicly by removing all identifiers of participants (and families) and assigned them with codes and/or pseudonyms. Conflict of interestThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Competing interests The authors declare no competing interests. Conflict of interest The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

"Funding Research reported on this manuscript from the HPTN 071 (PopART) data was supported by the National Institute of Allergy and Infectious Diseases (NIAID) under Cooperative Agreements UM1-AI068619, UM1-AI068617, and UM1-AI068613, with funding from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Additional funding is provided by the International Initiative for Impact Evaluation (3ie) with support from the Bill & Melinda Gates Foundation, as well as by NIAID, the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH), all part of NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NIMH, NIDA, PEPFAR, 3ie, or the Bill & Melinda Gates Foundation."